Lifecore Biomedical (LFCR) Tops Q1 EPS by 43c

Lifecore Biomedical (NASDAQ: LFCR) reported Q1 EPS of $0.43. Revenue for the quarter came in at $23.2 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• RBC Capital Upgrades Central Asia Metals plc (CAML:LN) to Sector Perform
• Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD66 at RBC Capital
• Citizens Starts Lucky Strike Entertainment (LUCK) at Market Perform